Clinic Treatment in PA for COPD

What is Chronic Obstructive Pulmonary Disease (COPD)?

Chronic obstructive pulmonary disease (COPD) is a progressive form of lung disease ranging from mild to severe. It is characterized by a restriction of airflow into and out of the lungs that makes breathing difficult. COPD is the umbrella term for sufferers who have been diagnosed with or show signs of emphysema and/or chronic bronchitis. In Pittsburgh, COPD is a health concern for many, in part due to air pollution levels and occupational hazards. In 2015, the Lung Institute will open a clinic treatment in PA for COPD.

COPD in Pennsylvania

Unfortunately many Pennsylvania residents suffer from chronic obstructive pulmonary disease (COPD). When diagnosed with COPD, a person might feel overwhelmed or hopeless because, unfortunately, COPD cannot be cured. Things like medications, inhalers and oxygen therapy help lessen the symptoms of COPD.  There is a relatively new cellular therapy that has been very effective for many patients. The cellular therapy is a minimally invasive procedure that harnesses the body’s own healing properties. The Lung Institute specializes in treating patients with debilitating lung disease with cellular therapy.

What is Cellular Therapy for COPD?

Cellular therapy harnesses the body’s natural healing capabilities to expedite the healing process. At the Lung Institute, the stem cell procedure is a three day outpatient treatment, where cells are extracted from a person’s blood, fat tissue or bone marrow. After the cells have been extracted, they are treated in a lab on site and then reintroduced into the body directly into the damaged tissue areas. Cells are how your body heals itself after getting a cut or bruise, however, sometimes this healing process can move more slowly than the disease progresses, like in the case of lung disease. By targeting many cells directly onto the damaged tissue, the body has the opportunity to heal itself more quickly. In most cases this results in stopping the progression of the disease or even improved lung function.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomat of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Dr. Coleman and the Lung Institute look forward to being able to treat more patients by opening a fourth clinic in Pittsburgh. The clinic will open July 13, 2015 and the ribbon cutting ceremony will be attended by medical staff, the Lung Institute’s corporate team members and local Pittsburgh Chamber of Commerce Members.

For many who suffer from COPD in Pennsylvania, the Lung Institute might be the answer. If you or a loved one suffers from a lung disease like COPD, contact one of our patient coordinators today at (800) 729-3065 to see if you qualify.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.